10-Q

Company

Nurix Therapeutics, Inc.

Filed

April 8, 2025

Period of Report

February 28, 2025

Accession Number

0001549595-25-000055

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →